Ruxolitinib as potential targeted therapy for patients with JAK2 rearrangements


Chase, A., Bryant, C., Score, J., Haferlach, C., Grossmann, V., Schwaab, J., Hofmann, W.-K., Reiter, A. and Cross, N. C. P. (2012) Ruxolitinib as potential targeted therapy for patients with JAK2 rearrangements. Haematologica, 98, (3), 404-408. (doi:10.3324/haematol.2012.067959).

Download

Full text not available from this repository.

Item Type: Article
Digital Object Identifier (DOI): doi:10.3324/haematol.2012.067959
ISSNs: 0390-6078 (print)
1592-8721 (electronic)
Related URLs:
Subjects: R Medicine > RC Internal medicine
Divisions: Faculty of Medicine > Human Development and Health
ePrint ID: 342167
Date :
Date Event
8 August 2012["eprint_fieldopt_dates_date_type_inpress" not defined]
March 2013Published
Date Deposited: 14 Aug 2012 09:03
Last Modified: 31 Mar 2016 14:33
URI: http://eprints.soton.ac.uk/id/eprint/342167

Actions (login required)

View Item View Item